Condition: Localized Prostate Carcinoma · Prostate Cancer (Adenocarcinoma) · Prostate Hyperplasia · Sponsor: University of Zurich
The aim of this phase II international multicenter study is to evaluate the safety, feasibility, and efficacy of CT or MRI-adaptive SBRT, delivered in five weekly fractions, in patients with newly diagnosed localized prostate cancer who have lower urinary tract symptoms and/or prostatic hyperplasia.
This description comes directly from the study's public registry record.
Radiation Oncology Study Office · +41442554108 · RAO_akademischesoffice@usz.ch
Always discuss trial participation with your own doctor first.
| Klinik für Radioonkologie und Strahlentherapie, Universitätsklinikum Heidelberg | Heidelberg, Baden-Wurttemberg, Germany | Not Yet Recruiting |
| Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Universitätsklinikum LMU | Munich, Bavaria, Germany | Not Yet Recruiting |
| University Hospital Zurich, Department of Radio-Oncology | Zurich, Canton of Zurich, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06834152